These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8947520)

  • 1. Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors.
    Vageli D; Kiaris H; Delakas D; Anezinis P; Cranidis A; Spandidos DA
    Cancer Lett; 1996 Oct; 107(2):241-7. PubMed ID: 8947520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers.
    Przybojewska B; Jagiello A; Jalmuzna P
    Cancer Genet Cytogenet; 2000 Aug; 121(1):73-7. PubMed ID: 10958945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of RAS gene family in specimens of bladder cancer.
    Karimianpour N; Mousavi-Shafaei P; Ziaee AA; Akbari MT; Pourmand G; Abedi A; Ahmadi A; Afshin Alavi H
    Urol J; 2008; 5(4):237-42. PubMed ID: 19101897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of N-ras gene mutations in urothelial cell carcinomas of the urinary bladder in the Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Bhat AY; Wani SM; Siddiqi MA
    Asian Pac J Cancer Prev; 2009; 10(6):1063-6. PubMed ID: 20192584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in superficial bladder cancer in a tumor-model-system (RBT).
    Knopf HJ; von Moorselaar RJ; Debruyne FM; Schalken JA
    Investig Urol (Berl); 1994; 5():76-9. PubMed ID: 7719325
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population.
    Pandith AA; Shah Z; Rasool R; Dil-Afroze ; Yousuf A; Parveen N; Wani S; Siddiqi M
    Tumori; 2010; 96(6):993-8. PubMed ID: 21388064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bracken fern-induced malignant tumors in rats: absence of mutations in p53, H-ras and K-ras and no microsatellite instability.
    Freitas RN; Brasileiro-Filho G; Silva ME; Pena SD
    Mutat Res; 2002 Feb; 499(2):189-96. PubMed ID: 11827712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Enomoto T; Ward JM; Perantoni AO
    Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Activation of Fibroblast Growth Factor Receptor-3 and RAS Genes as Non-Overlapping Mutual Exclusive Events in Urinary Bladder Cancer.
    Pandith AA; Hussain A; Khan MS; Shah ZA; Wani MS; Siddiqi MA
    Asian Pac J Cancer Prev; 2016; 17(6):2787-93. PubMed ID: 27356691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras mutations and expression in head and neck squamous cell carcinomas.
    Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
    Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors.
    Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC
    J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder.
    Olderøy G; Daehlin L; Ogreid D
    Anticancer Res; 1998; 18(4A):2675-8. PubMed ID: 9703927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population.
    Nanda MS; Sameer AS; Syeed N; Shah ZA; Murtaza I; Siddiqi MA; Ali A
    Urol J; 2010; 7(3):168-73. PubMed ID: 20845292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.
    Huang WC; Taylor S; Nguyen TB; Tomaszewski JE; Libertino JA; Malkowicz SB; McGarvey TW
    DNA Cell Biol; 2002 Oct; 21(10):707-15. PubMed ID: 12443540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.